Login Join us
BACK

Popular

Showing items 181-190 of 200

Departments Issue Guidance on Surprise Billing IDR Process and Gag Clause Attestations

Topic: Policy & Advocacy

Tags: Coverage Expansion, Payment & Delivery Reform,

Departments Issue FAQs Addressing Issues Under No Surprises Act and Transparency Rules

Topic: Policy & Advocacy

Tags: Compliance, COVID-19, Health Accounts,

Departments Withdraw Proposed Rule Requiring Coverage of OTC Contraceptives without Cost-Sharing

Topic: Policy & Advocacy

Tags: Pharmacy, Preventive Services, Pharmacy/Prescription Drugs,

President Biden Calls on Congress to Reduce Rx Prices

Topic: Policy & Advocacy

Tags: Pharmacy/Prescription Drugs,

Business Group on Health Contributes to Amicus Briefs in Legal Challenges Relating to ERISA Preemption and Surprise Billing

Topic: Policy & Advocacy

Tags: Mental Health Parity,

Comments to CMS on a Proposed Rule Impacting Medicare Hospital Inpatient Payments

Topic: Policy & Advocacy

Tags: Payment & Delivery Reform,

Departments Respond to Court Order with Proposed Rule on Federal Independent Dispute Resolution Fees

Topic: Policy & Advocacy

Tags: Surprise Billing,

Should Electronic Disclosures Extend to Health and Welfare Plans?

Topic: Policy & Advocacy

Tags: Employee Retirement Income Security Act (ERISA),

Departments Issue FAQs on Two Unrelated Items: Addressing Non-English Language Plan Notices for 2025; and No Surprises Act Batching Provisions

Topic: Policy & Advocacy

Tags: Compliance, Surprise Billing,

Utilizing Financing Mechanisms to Implement a Global Consistency Strategy

Topic: Global

Tags: Global Benefits Management, Governance,

Showing items181-190 of 200